Cargando…

Antimicrobial Chemotherapy.

Antimicrobial agents are essential for the treatment of life-threatening infections and for managing the burden of minor infections in the community. In addition, they play a key role in organ and bone marrow transplantation, cancer chemotherapy, artificial joint and heart valve surgery. Unlike othe...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Finch, Roger
Otros Autores: Davey, Peter, Wilcox, Mark H.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Oxford : OUP Oxford, 2012.
Edición:6th ed.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Mu 4500
001 EBOOKCENTRAL_ocn778339644
003 OCoLC
005 20240329122006.0
006 m o d
007 cr |n|---|||||
008 120227s2012 enk o 000 0 eng d
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d OCLCQ  |d YDXCP  |d LUN  |d OCLCO  |d OCLCF  |d OCLCO  |d OCLCQ  |d OCLCO  |d ZCU  |d MERUC  |d IQU  |d OCLCQ  |d OCLCA  |d ICG  |d OCLCQ  |d DKC  |d AU@  |d OCLCQ  |d CASUM  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCO  |d OCLCA 
019 |a 903554245 
020 |a 9780191628658 
020 |a 0191628654 
020 |z 9780199697656  |q (pbk.) 
020 |z 0199697655  |q (pbk.) 
029 1 |a DEBBG  |b BV044049738 
035 |a (OCoLC)778339644  |z (OCoLC)903554245 
050 4 |a RM267 
060 4 |a QV 250  |b A629 2012 
060 0 0 |a 2012 C-261 
060 1 0 |a QV 250 
082 0 4 |a 616.90461 
049 |a UAMI 
100 1 |a Finch, Roger. 
245 1 0 |a Antimicrobial Chemotherapy. 
250 |a 6th ed. 
260 |a Oxford :  |b OUP Oxford,  |c 2012. 
300 |a 1 online resource (934 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
505 0 |a Cover Page; Title Page; Copyright Page; Preface; Contents; List of abbreviations; Historical introduction; Part 1 General properties of antimicrobial agents; 1 Inhibitors of bacterial cell wall synthesis; 2 Inhibitors of bacterial protein synthesis; 3 Synthetic antibacterial agents and miscellaneous antibiotics; 4 Antiviral agents; 5 Antiretroviral agents; 6 Drugs used in the treatment of viral hepatitis; 7 Antifungal agents; 8 Antiprotozoal and anthelminthic agents; Part 2 Resistance to antimicrobial agents; 9 The problem of resistance; 10 The genetics and mechanisms of acquired resistance. 
505 8 |a 11 Control of the spread of resistance and Clostridium difficile infectionPart 3 General principles of usage of antimicrobial agents; 12 Laboratory investigations and the treatment of infection; 13 General principles of the treatment of infection; 14 Pharmacokinetic and pharmacodynamic principles; 15 Prescribing in children and the elderly; 16 Outpatient parenteral antimicrobial therapy (OPAT); 17 Adverse drug reactions; 18 Chemoprophylaxis and immunization; 19 Guidelines, formularies, and antimicrobial policies. 
505 8 |a 20 Antibiotic stewardship and the multi-professional antimicrobial management teamPart 4 Therapeutic use of antimicrobial agents; 21 Respiratory tract infections; 22 Topical use of antimicrobial agents; 23 Urinary infections; 24 Sexually transmitted infections; 25 Gastrointestinal infections; 26 Serious bloodstream infections; 27 Bone and joint infections; 28 Infections of the central nervous system; 29 Skin and soft tissue infections; 30 Tuberculosis and other mycobacterial diseases; 31 Infections in immunocompromised patients including HIV/AIDS; 32 Viral infections. 
505 8 |a 33 Management of HIV infection34 Treatment of chronic viral hepatitis; 35 Parasitic diseases; 36 The development and marketing of antimicrobial drugs; Recommendations for further reading; Index. 
520 |a Antimicrobial agents are essential for the treatment of life-threatening infections and for managing the burden of minor infections in the community. In addition, they play a key role in organ and bone marrow transplantation, cancer chemotherapy, artificial joint and heart valve surgery. Unlike other classes of medicines, they are vulnerable to resistance from mutations in target microorganisms, and their adverse effects may extend to other patients (increased risk ofcross-infection). As a consequence, there is a constant requirement for new agents, as well as practices that ensure the continu. 
588 0 |a Print version record. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Anti-infective agents. 
650 0 |a Communicable diseases  |x Chemotherapy. 
650 0 |a Therapeutics. 
650 0 |a Drug resistance in microorganisms. 
650 1 2 |a Anti-Infective Agents  |x therapeutic use 
650 1 2 |a Therapeutics 
650 2 2 |a Anti-Infective Agents  |x pharmacology 
650 2 2 |a Drug Resistance, Microbial 
650 2 2 |a Infections  |x drug therapy. 
650 2 |a Anti-Infective Agents 
650 6 |a Antiinfectieux. 
650 6 |a Maladies infectieuses  |x Chimiothérapie. 
650 6 |a Thérapeutique. 
650 6 |a Micro-organismes  |x Résistance aux médicaments. 
650 7 |a treating (health care function)  |2 aat 
650 7 |a Therapeutics  |2 fast 
650 7 |a Drug resistance in microorganisms  |2 fast 
650 7 |a Anti-infective agents  |2 fast 
650 7 |a Communicable diseases  |x Chemotherapy  |2 fast 
655 4 |a Internet Resources. 
700 1 |a Davey, Peter. 
700 1 |a Wilcox, Mark H. 
776 0 8 |i Print version:  |a Finch, Roger.  |t Antimicrobial Chemotherapy.  |d Oxford : OUP Oxford, ©2012  |z 9780199697656 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=845862  |z Texto completo 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL845862 
938 |a YBP Library Services  |b YANK  |n 7459630 
938 |a YBP Library Services  |b YANK  |n 12692374 
994 |a 92  |b IZTAP